Nisa Investment Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-500
Closed -$83 2375
2021
Q2
$83 Hold
500
﹤0.01% 1788
2021
Q1
$77 Hold
500
﹤0.01% 1869
2020
Q4
$63K Sell
500
-811
-62% -$90.7K ﹤0.01% 1925
2020
Q3
$133K Buy
+1,311
New +$134K ﹤0.01% 1449
2020
Q2
Sell
-6,855
Closed -$569K 2133
2020
Q1
$569K Hold
6,855
0.01% 882
2019
Q4
$762K Sell
6,855
-905
-12% -$93.1K 0.01% 970
2019
Q3
$770K Sell
7,760
-313
-4% -$31.1K 0.01% 942
2019
Q2
$800K Hold
8,073
0.01% 926
2019
Q1
$890K Buy
8,073
+697
+9% +$72.8K 0.01% 877
2018
Q4
$678K Sell
7,376
-15,915
-68% -$1.61M 0.01% 908
2018
Q3
$2.57M Buy
+23,291
New +$2.42M 0.02% 562

Other funds holding PRAH

Nisa Investment Advisors's PRAH Position: Q3 2021 in Review

Nisa Investment Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 500 shares — an estimated $83 sold.

Nisa Investment Advisors first reported a position in PRAH in Q3 2018 and held it in 11 quarters. The position peaked at $2.57M in Q3 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Nisa Investment Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 500 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $83.
  • Nisa Investment Advisors first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 11 quarters.
  • Nisa Investment Advisors's PRA Health Sciences, Inc. position peaked at $2.57M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Nisa Investment Advisors's 13F filing for Q3 2021, filed 18 Oct 2021.